Literature DB >> 9234733

Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells.

M Honma1, L S Zhang, M Hayashi, K Takeshita, Y Nakagawa, N Tanaka, T Sofuni.   

Abstract

Allelic loss and translocation are critical mutational events in human tumorigenesis. Allelic loss, which is usually identified as loss of heterozygosity (LOH), is frequently observed at tumor suppressor loci in various kinds of human tumors. It is generally thought to result from deletion or mitotic recombination between homologous chromosomes. In this report, we demonstrate that illegitimate (nonhomologous) recombination strongly contributes to the generation of allelic loss in p53-mutated cells. Spontaneous and X-ray-induced LOH mutations at the heterozygous thymidine kinase (tk) gene, which is located on the long arm of chromosome 17, from normal (TK6) and p53-mutated (WTK-1) human lymphoblastoid cells were cytogenetically analyzed by chromosome 17 painting. We observed unbalanced translocations in 53% of LOH mutants spontaneously arising from WTK-1 cells but none spontaneously arising from TK6 cells. We postulate that illegitimate recombination was occurring between nonhomologous chromosomes after DNA replication, leading to allelic loss and unbalanced translocations in p53-mutated WTK-1 cells. X-ray irradiation, which induces DNA double-strand breaks (DSBs), enhanced the generation of unbalanced translocation more efficiently in WTK-1 than in TK6 cells. This observation implicates the wild-type p53 protein in the regulation of homologous recombination and recombinational DNA repair of DSBs and suggests a possible mechanism by which loss of p53 function may cause genomic instability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234733      PMCID: PMC232329          DOI: 10.1128/MCB.17.8.4774

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

Review 3.  Loss of constitutional heterozygosity in human cancer.

Authors:  D Lasko; W Cavenee; M Nordenskjöld
Journal:  Annu Rev Genet       Date:  1991       Impact factor: 16.830

Review 4.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

Review 5.  Homologous recombination in mammalian cells.

Authors:  R J Bollag; A S Waldman; R M Liskay
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

6.  Different cytotoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor.

Authors:  S A Amundson; F Xia; K Wolfson; H L Liber
Journal:  Mutat Res       Date:  1993-04       Impact factor: 2.433

7.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

Authors:  Y Yin; M A Tainsky; F Z Bischoff; L C Strong; G M Wahl
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

8.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

9.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

10.  p53-catalyzed annealing of complementary single-stranded nucleic acids.

Authors:  P Oberosler; P Hloch; U Ramsperger; H Stahl
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

View more
  11 in total

1.  p53 C-terminal interaction with DNA ends and gaps has opposing effect on specific DNA binding by the core.

Authors:  S B Zotchev; M Protopopova; G Selivanova
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

2.  The detection of inherent homologous recombination between repeat sequences in H. pylori 26695 by the PCR-based method.

Authors:  Yajuan Fu; Reyna Cristina Zepeda-Gurrola; Germán Rubén Aguilar-Gutiérrez; Edgar E Lara-Ramírez; Erick J De Luna-Santillana; Isabel Cristina Rodríguez-Luna; Alejandro Sánchez-Varela; Ricardo Carreño-López; Víctor Ricardo Moreno-Medina; Mario A Rodríguez-Pérez; Yolanda López-Vidal; Xianwu Guo
Journal:  Curr Microbiol       Date:  2013-10-06       Impact factor: 2.188

3.  Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth.

Authors:  Jagannath Pal; Mariateresa Fulciniti; Puru Nanjappa; Leutz Buon; Yu-Tzu Tai; Pierfrancesco Tassone; Nikhil C Munshi; Masood A Shammas
Journal:  Cancer Genomics Proteomics       Date:  2012 Mar-Apr       Impact factor: 4.069

4.  p53 null fluorescent yellow direct repeat (FYDR) mice have normal levels of homologous recombination.

Authors:  Dominika M Wiktor-Brown; Michelle R Sukup-Jackson; Saja A Fakhraldeen; Carrie A Hendricks; Bevin P Engelward
Journal:  DNA Repair (Amst)       Date:  2011-10-12

5.  Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer.

Authors:  Dae-Sung Yoon; Robert P Wersto; Weibo Zhou; Francis J Chrest; Elizabeth S Garrett; Teag Kyu Kwon; Edward Gabrielson
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Dysfunctional homologous recombination mediates genomic instability and progression in myeloma.

Authors:  Masood A Shammas; Robert J Shmookler Reis; Hemanta Koley; Ramesh B Batchu; Cheng Li; Nikhil C Munshi
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

7.  Elevated mutagenesis and decreased DNA repair at a transgene are associated with proliferation but not apoptosis in p53-deficient cells.

Authors:  Jason H Bielas; John A Heddle
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

8.  Recombination and its roles in DNA repair, cellular immortalization and cancer.

Authors:  M A Shammas; R J Shmookler Reis
Journal:  Age (Omaha)       Date:  1999-04

9.  Threshold effects of nitric oxide-induced toxicity and cellular responses in wild-type and p53-null human lymphoblastoid cells.

Authors:  Chun-Qi Li; Bo Pang; Tanyel Kiziltepe; Laura J Trudel; Bevin P Engelward; Peter C Dedon; Gerald N Wogan
Journal:  Chem Res Toxicol       Date:  2006-03       Impact factor: 3.739

10.  Genomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome.

Authors:  J Pal; R Bertheau; L Buon; A Qazi; R B Batchu; S Bandyopadhyay; R Ali-Fehmi; D G Beer; D W Weaver; R J Shmookler Reis; R K Goyal; Q Huang; N C Munshi; M A Shammas
Journal:  Oncogene       Date:  2011-03-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.